Clinical trial
Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome
NCT00065923 · Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH · Completed
Key facts
| NCT number | NCT00065923 |
|---|---|
| Title | Treatment of Self-Injurious Behavior in Individuals With Prader-Willi Syndrome |
| Official title | Topiramate Effects on SIB in Prader-Willi Syndrome |
| Lead sponsor | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), NIH |
| Status | Completed |
| Study type | Interventional |
| Conditions | Prader-Willi Syndrome, Self-Injurious Behavior |
| Intervention type | Drug |
| Interventions | Topiramate |
| Enrollment | 10 |
| Start date | Jul 1, 2002 |
| Primary completion | Dec 1, 2005 |
| First posted | Aug 5, 2003 |
| Last update posted | May 1, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: